Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

Similar articles for PubMed (Select 23471264)

1.

A new approach to classification of disease severity and progression of COPD.

Mannino DM, Diaz-Guzman E, Pospisil J.

Chest. 2013 Oct;144(4):1179-85. doi: 10.1378/chest.12-2674.

PMID:
23471264
2.

[How exactly can we predict the prognosis of COPD].

Atiş S, Kanik A, Ozgür ES, Eker S, Tümkaya M, Ozge C.

Tuberk Toraks. 2009;57(3):289-97. Turkish.

PMID:
19787468
3.

BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.

Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, Godoy I.

Am J Med Sci. 2010 Jan;339(1):10-4. doi: 10.1097/MAJ.0b013e3181bb8111.

PMID:
19926966
4.

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.

Chong J, Karner C, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD009157. doi: 10.1002/14651858.CD009157.pub2. Review.

PMID:
22972134
5.

The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD.

Sundh J, Janson C, Lisspers K, Ställberg B, Montgomery S.

Prim Care Respir J. 2012 Sep;21(3):295-301. doi: 10.4104/pcrj.2012.00054.

6.

Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?

Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU.

Chest. 2006 Oct;130(4):1117-28.

PMID:
17035446
7.

The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.

Lindberg A, Lundbäck B.

Clin Respir J. 2008 Oct;2 Suppl 1:64-71. doi: 10.1111/j.1752-699X.2008.00086.x.

PMID:
20298352
8.

Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey.

Voll-Aanerud M, Eagan TM, Plana E, Omenaas ER, Bakke PS, Svanes C, Siroux V, Pin I, Antó JM, Leynaert B.

Health Qual Life Outcomes. 2010 Sep 27;8:107. doi: 10.1186/1477-7525-8-107.

9.

Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.

Borrell E, Rodríguez M, Torán P, Muñoz L, Pera G, Montellà N, Monteagudo M, Urrea M, Puigfel Y, Negrete A, Mezquiriz X, Domènech C, Lacasta A, García ML, Maneus S, Tintoré G.

BMC Public Health. 2009 Jan 9;9:8. doi: 10.1186/1471-2458-9-8.

10.

Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.

Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K.

Int J Chron Obstruct Pulmon Dis. 2011;6:521-6. doi: 10.2147/COPD.S24420. Epub 2011 Oct 11.

11.

Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.

Suissa S, Dell'Aniello S, Ernst P.

Thorax. 2012 Nov;67(11):957-63. doi: 10.1136/thoraxjnl-2011-201518. Epub 2012 Jun 8.

12.

Validation of a new questionnaire with generic and disease-specific qualities: the McGill COPD Quality of Life Questionnaire.

Pakhale S, Wood-Dauphinee S, Spahija A, Collet JP, Maltais F, Bernard S, Baltzan M, Rouleau M, Bourbeau J; Respiratiory Network of the FRSQ.

Can Respir J. 2012 Nov-Dec;19(6):367-72.

13.

Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease.

Ohno Y, Iwasawa T, Seo JB, Koyama H, Takahashi H, Oh YM, Nishimura Y, Sugimura K.

Am J Respir Crit Care Med. 2008 May 15;177(10):1095-102. doi: 10.1164/rccm.200709-1322OC. Epub 2008 Feb 14.

PMID:
18276941
14.

The COPD severity score: a dynamic prediction tool for health-care utilization.

Omachi TA, Yelin EH, Katz PP, Blanc PD, Eisner MD.

COPD. 2008 Dec;5(6):339-46. doi: 10.1080/15412550802522700.

15.

The impact of heart failure on the classification of COPD severity.

Güder G, Rutten FH, Brenner S, Angermann CE, Berliner D, Ertl G, Jany B, Lammers JW, Hoes AW, Störk S.

J Card Fail. 2012 Aug;18(8):637-44. doi: 10.1016/j.cardfail.2012.05.008. Epub 2012 Jul 13.

PMID:
22858080
16.

Classifying the severity of COPD: are the new severity scales better than the old?

Esteban C, Quintana JM, Egurrola M, Moraza J, Aburto M, Pérez-Izquierdo J, Basualdo LV, Capelastegui A.

Int J Tuberc Lung Dis. 2009 Jun;13(6):783-90.

PMID:
19460257
17.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA.

Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi: 10.2147/COPD.S36997. Epub 2012 Nov 1.

18.

The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.

Lin YX, Xu WN, Liang LR, Pang BS, Nie XH, Zhang J, Wang H, Liu YX, Wang DQ, Xu ZY, Wang HW, Zhang HS, He ZY, Yang T, Wang C.

Chin Med J (Engl). 2009 Dec 20;122(24):2939-44.

PMID:
20137478
19.

Study of the burden on patients with chronic obstructive pulmonary disease.

Izquierdo JL, Barcina C, Jiménez J, Muñoz M, Leal M.

Int J Clin Pract. 2009 Jan;63(1):87-97. doi: 10.1111/j.1742-1241.2008.01936.x.

20.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk